TriSalus Life Sciences Launches PREDICTT Trial
WESTMINSTER, Colo. – May 4, 2026 TriSalus Life Sciences has announced the initiation of patient enrollment for its PREDICTT...
AI drug discovery artificial intelligence Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WESTMINSTER, Colo. – May 4, 2026 TriSalus Life Sciences has announced the initiation of patient enrollment for its PREDICTT...
San Diego, U.S. | April 15, 2026 ARS Pharmaceuticals has achieved a major regulatory milestone with Health Canada approval...
SAN DIEGO, March 27, 2026 ARS Pharmaceuticals has received U.S. FDA approval to update the labeling of neffy® (epinephrine...
